Overview

Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
This is a study for people diagnosed with hypertension to compare the safety and effectiveness of aliskiren alone and in combination with atenolol. Each patient will be in the study for 12 weeks.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Atenolol